Systolic Blood Pressure and Cardiovascular Risk in Patients With Diabetes: A Prospective Cohort Study.
Journal article
Rao S. et al, (2022), Hypertension
Blood pressure reduction and major cardiovascular events in people with and without type 2 diabetes - Authors' reply.
Journal article
Nazarzadeh M. et al, (2022), Lancet Diabetes Endocrinol, 10, 841 - 842
Blood pressure and risk of venous thromboembolism: a cohort analysis of 5.5 million UK adults and Mendelian randomization studies.
Journal article
Nazarzadeh M. et al, (2022), Cardiovasc Res
Correction: Elevated blood pressure, antihypertensive medications and bone health in the population: revisiting old hypotheses and exploring future research directions.
Journal article
Canoy D. et al, (2022), Osteoporos Int
Blood pressure-lowering treatment for prevention of major cardiovascular diseases in people with and without type 2 diabetes: an individual participant-level data meta-analysis.
Journal article
Nazarzadeh M. et al, (2022), Lancet Diabetes Endocrinol
How Much Lowering of Blood Pressure Is Required to Prevent Cardiovascular Disease in Patients With and Without Previous Cardiovascular Disease?
Journal article
Canoy D. et al, (2022), Current Cardiology Reports, 24, 851 - 860
Investigating the association of environmental exposures and all-cause mortality in the UK Biobank using sparse principal component analysis.
Journal article
Mamouei M. et al, (2022), Sci Rep, 12
ABCG2, SCN1A and CYP3A5 genes polymorphism and drug-resistant epilepsy in children: A case-control study
Journal article
Mousavi SF. et al, (2022), Seizure, 97, 58 - 62
The Blood Pressure Lowering Treatment Trialists' Collaboration: methodological clarifications of recent reports.
Journal article
Nazarzadeh M. et al, (2022), J Hypertens
Antihypertensive drug effects on long-term blood pressure: an individual-level data meta-analysis of randomised clinical trials
Journal article
Canoy D. et al, (2022), Heart
The association of dietary insulin load and index with the risk of cancer and cancer mortality: a systematic review and meta-analysis
Journal article
Teymoori F. et al, (2022), Journal of Diabetes and Metabolic Disorders
Blood pressure lowering and risk of new-onset type 2 diabetes: an individual participant data meta-analysis.
Journal article
Nazarzadeh M. et al, (2021), Lancet, 398, 1803 - 1810
Blood pressure treatment: how low should you go? - Authors' reply.
Journal article
Rahimi K. et al, (2021), Lancet, 398, 1684 - 1685
Elevated blood pressure, antihypertensive medications and bone health in the population: Revisiting old hypotheses and exploring future research directions
Journal article
CANOY D. et al, (2021), Osteoporosis International
Age-stratified and blood-pressure-stratified effects of blood-pressure-lowering pharmacotherapy for the prevention of cardiovascular disease and death: an individual participant-level data meta-analysis.
Journal article
Blood Pressure Lowering Treatment Trialists' Collaboration None., (2021), Lancet, 398, 1053 - 1064
Age and blood pressure stratified effects of blood pressure-lowering pharmacotherapy for the prevention of cardiovascular disease and death: an individual-level meta-analysis of 358,707 randomised participants
Journal article
MCMANUS R. et al, (2021), The Lancet
Multi-morbidity and blood pressure trajectories in hypertensive patients: A multiple landmark cohort study
Journal article
Tran J. et al, (2021), PLOS Medicine, 18, e1003674 - e1003674
Blood pressure-lowering treatment for the prevention of cardiovascular events in patients with atrial fibrillation: An individual participant data meta-analysis
Journal article
Pinho-Gomes A-C. et al, (2021), PLOS Medicine, 18, e1003599 - e1003599
Blood pressure-lowering treatment for the prevention of cardiovascular events in patients with atrial fibrillation: An individual participant data meta-analysis
Conference paper
Pinho-Gomes AC. et al, (2021), PLoS Medicine, 18
Antihypertensive treatment and risk of cancer: an individual participant data meta-analysis.
Journal article
Copland E. et al, (2021), Lancet Oncol, 22, 558 - 570